Need a specific person's email?
Browse R-Pharm's employee directory (about 516 employees) and reveal verified emails free.
R-Pharm's most common email format is First.Last@r-pharm.com (ex. John.Doe@r-pharm.com), used for 58% of r-pharm.com addresses. R-Pharm uses 6 email patterns across 2 domains: r-pharm.com and rpharm.ru. Percentages are the share of addresses within each domain.
| Format | Example | Share of r-pharm.com |
|---|---|---|
| First.Last@r-pharm.comMost common | John.Doe@r-pharm.com | |
| Last@r-pharm.com | Doe@r-pharm.com | |
| Last_First@r-pharm.com | Doe_John@r-pharm.com | |
| Last.F@r-pharm.com | Doe.J@r-pharm.com |
| Format | Example | Share of rpharm.ru |
|---|---|---|
| Last@rpharm.ruMost common | Doe@rpharm.ru | |
| First@rpharm.ru | John@rpharm.ru |
Browse R-Pharm's employee directory (about 516 employees) and reveal verified emails free.
Pharmaceutical ManufacturingMoskow, Russia501-1000 Employees
R-Pharm is a Moscow-based pharmaceutical manufacturing company in Russia. It focuses on research, development, manufacturing and commercialization of pharmaceuticals, as well as laboratory equipment and medical devices. The company lists 501-1000 employees, while the group employs more than 5000 people across its operations. R-Pharm operates 11 manufacturing sites that meet international quality standards and has established strategic partnerships, production localization and technology transfer agreements with leading global manufacturers of pharmaceuticals and medical equipment. The group's research and development activity includes a pipeline of more than 100 knowledge-intensive products. Through corporate social responsibility initiatives, it supports projects related to disease awareness, healthy lifestyles, education, and the development of pharmaceutical professionals.
Most common format
First.Last@r-pharm.com
Example: John.Doe@r-pharm.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.